[1] 刘纪君,梅传忠.冠心病新危险因素在预测冠状动脉病变严重程度中的价值研究进展[J].蚌埠医学院学报,2016,41(4):558.
[2] HARTIALA J,SCHWARTZMAN WS,GABBAY J,et al.The genetic architecture of coronary artery disease:current knowledge and future opportunities[J].Curr Atheroscler Rep,2017,19(2):6.
[3] ASSIMES TL,ROBERTS R.Genetics:implications for prevention and management of coronary artery disease[J].J Am Coll Cardiol,2016,68(25):2797.
[4] 赵平,常培叶,南景龙,等.CYP4F2基因多态性与蒙古族冠心病的相关性研究[J].心血管康复医学杂志,2016,25(1):18.
[5] 刘璐,曹剑.环氧二十碳三烯酸防治心血管疾病的研究进展[J].中华老年心脑血管病杂志,2014,16(12):1329.
[6] 闫璐璐,张永珍.花生四烯酸细胞色素 P450代谢途径在心力衰竭中作用的研究进展[J].中国心血管杂,2015,20(2):151.
[7] 邓淑敏,刘芳,李蕾,等.CYP4F2基因单核苷酸多态与缺血性脑卒中的相关性[J].中国血液流变学杂志.2012,22(2):191.
[8] 吕天成.老年男性冠心病患者血清总胆固醇水平与其病死率的相关性探讨[J].蚌埠医学院学报,2016,41(3):377.
[9] ROBERTS R.Genetics-current and future role in the prevention and management of coronary artery disease[J].Curr Atheroscler Rep,2016,18(12):78.
[10] AGIRBASLI M,GUNEY AI,OZTURHAN HS,et al.Multifactor dimensionality reduction analysis of MTHFR,PAI-1,ACE,PON1,and eNOS gene polymorphisms in patients with early onset coronary artery disease [J].Eur J Cardiovasc Prev Rehabil,2011,18(6):803.
[11] 刘俊花,石磊,赵树进.细胞色素P450(CYP450)4All与CYP4F2基因多态性与心血管疾病的相关性[J].中国临床药理学杂志,2012,28(5):392.
[12] WARDA NC,CROFTA KD,PUDDEYA IB,et al.The effect of a single necleotide polymorphism of the CYP4F2 gene on blood pressure and 20-hydroxyeicosatetraenoic acidexcretion after weight loss [J].J Hypertens,2014,32(7):1495.
[13] 但三利,林润英,邹晓霞.CYP4F2基因多态性及其单体与重庆汉族人群冠心病的相关性[J].中华老年心血管病杂志,2009,11(7):505.
[14] YU C,YAN Q,FU C,et al.CYP4F2 genetic polymorphisms are associated with coronary heart disease in a Chinese population[J].Lipids Health Dis,2014,13:83.